The Allstate Corporation logo ALL - The Allstate Corporation

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
1
BUY 19
HOLD 23
SELL 1
STRONG
SELL
0
| PRICE TARGET: $257.08 DETAILS
HIGH: $319.00
LOW: $213.00
MEDIAN: $251.50
CONSENSUS: $257.08
UPSIDE: 7.35%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate
Trading 30.1% below fair value
Current Price $239.48
Bear Case $291.52 21.7% upside ($291.52 - $239.48) / $239.48 = 21.7% ROTCE 20.0% → 4.00x TBV
Fair Value $342.77 43.1% upside ($342.77 - $239.48) / $239.48 = 43.1% ROTCE 25.0% → 4.00x TBV
Bull Case $445.61 86.1% upside ($445.61 - $239.48) / $239.48 = 86.1% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

49.5%
6.0%

Key Value Driver

ROTCE (49.5%) vs. cost of equity (6.0%)

Implied Market Multiple 2.97x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $257.08 from 44 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $342.77 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $257.08 (from 44 analysts). Our estimate is 48% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly